文献速递乳腺癌放疗

新冠疫情早期加拿大某大型学术癌症中心乳腺放疗利用的快速适应

Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada.
PubMed 文献 · Adv Radiat Oncol · 2020-06-19

该研究比较了2020年3月1日至4月30日与2019年同期在加拿大安大略省某大型学术癌症中心启动乳腺放疗的患者数量、放疗类型和年龄。结论认为疫情早期乳腺放疗启动数显著减少,放疗优先分配给肿瘤风险较高需RNI的患者。

要点

  • 疫情紧急状态后乳腺放疗启动数下降39%(79 vs 129,P < .001)。
  • 接受RNI的比例相对增加(46% vs 29%),其中2020年50%的RNI病例采用大分割方案。

核心结论

  • 疫情早期乳腺放疗启动数显著减少,放疗优先分配给肿瘤风险较高需RNI的患者。

研究设计与样本

  • 回顾性比较2020年3月1日至4月30日与2019年同期在加拿大某大型学术癌症中心启动乳腺放疗的每周例数、放疗类型和患者年龄。

主要发现

  • 2020年放疗启动数较2019年下降39%(79 vs 129,P < .001)。

关键数值与推荐

  • 推荐在适当时采用较短的大分割方案,并按肿瘤风险优先安排放疗,低风险病例可省略或推迟放疗。

临床怎么用

  • 疫情等医疗危机期间可快速调整乳腺放疗策略,优先保障高肿瘤风险患者(如需RNI者)的放疗。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prioritization of radiation therapy by oncologic risk and omission or deferral of radiation therapy for lower risk cases. Timely adoption of these measures reduces COVID-19 risk to both patients and health care workers and preserves resources. Herein, we present our early response and adaptation of breast radiation therapy utilization during the COVID-19 pandemic at a large academic cancer center in Canada. METHODS AND MATERIALS: A state of emergency was announced in Ontario on March 17, 2020, owing to the COVID-19 pandemic. Emergency guidelines were instituted. To examine our response, the number of weekly breast radiation therapy starts, type of breast radiation therapy, and patient age were compared from March 1 to April 30, 2020 to the same period in 2019. RESULTS: After the declaration of emergency in Ontario, there was a decrease of 39% in radiation therapy starts in 2020 compared with 2019 (79 vs 129, P < .001). There was a relative increase in the proportion of patients receiving regional nodal irradiation (RNI) in 2020 compared with 2019 (46% vs 29%, respectively), with the introduction of hypofractionated RNI in 2020 (27 of 54 cases, 50%). A smaller proportion of patients starting radiation therapy were aged >50 years in 2020, 66% (78 of 118) versus 83% (132 of 160) in 2019, P = .0027. CONCLUSIONS: A significant reduction in breast radiation therapy starts was noted during the early response to the COVID-19 pandemic, with prioritization of radiation therapy to patients associated with higher oncologic risk requiring RNI. A quick response to a health care crisis is critical and is of particular importance for higher volume cancer sites where the potential effect on resources is greater.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Koch CA, Lee G, Liu ZA, et al. Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada. Adv Radiat Oncol. 2020. PMID: 32775788. doi:10.1016/j.adro.2020.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。